Gut microbiome analysis in patients with non-alcoholic fatty liver by 16S rRNA gene amplicon sequencing
Gut pathological microbial imbalance or dysbiosis is considered to be associated with non-alcoholic fatty liver disease. Although gut microbiome has impact on clinicopathological findings of non-alcoholic fatty liver status, the differences in their gut microbiomes have not been thoroughly investigated. Therefore we examined the human gut microbiota and fungal composition to determine its relationship with non-alcoholic fatty liver disease.